Share

Clinical Trials

4. Endpoints

Endpoints

A clinical trial endpoint is defined as a measure that allows us to decide whether the null hypothesis of a clinical trial should be accepted or rejected (Bakhai et al., 2006a). In a clinical trial, the null hypothesis states that there is no statistically significant difference between two treatments or strategies being compared with respect to the endpoint measure chosen.

Clinical trial endpoints can be classified as primary or secondary.

Primary endpoints measure outcomes that will answer the primary (or most important) question being asked by a trial, such as whether a new treatment is better at preventing disease-related death than the standard therapy. In this case, the primary endpoint would be based on the occurrence of disease-related deaths during the duration of the trial. The size of a trial is determined by the power needed to detect a difference in this primary endpoint.

Secondary endpoints ask other relevant questions about the same study; for example, whether there is also a reduction in disease measures other than death, or whether the new treatment reduces the overall cost of treating patients. When secondary endpoints are also important the trial must be powered sufficiently to detect a difference in both endpoints, and expert statistical and design advice may be needed.

Bakhai A, Chhabra A, Wang D. (2006a) Endpoints. In: D Wang & A Bakhai, (Ed.s). Clinical Trials: A practical guide to design, analysis and reporting. London: Remedica. 37-45.
Wang D, Clemens F, Clayton T. (2006f) Comparison of Means. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 197-216.
Wang D, Clayton T, Clemens F. (2006d) Comparison of Proportions. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 217-234.
Cox DR, Oakes D. (1984). Analysis of survival data. London: Chapman and Hall.
Wang D, Clayton T, Bakhai A. (2006b) Analysis of Survival Data. In: D Wang & A Bakhai, (Ed.s). Clinical trials: A practical guide to design, analysis and reporting. London: Remedica. 235-254.